Incremental Value of Cardiac MRI in Structural Heart Disease

• Research type

  Research Study

• Full title

  Incremental Value of Cardiac MRI in Structural Heart Disease to Current Clinical Management

• IRAS ID

  218297

• Contact name

  Estefania De Garate Iparraguirre

• Contact email

  ed15883@bristol.ac.uk

• Sponsor organisation

  University of Bristol

• Duration of Study in the UK

  3 years, 1 months, 1 days

• Research summary

  Structural heart disease refers to all non-coronary cardiovascular disease which often requires an intervention (percutaneous or open chest surgery) at some point in the natural history of the disease. Clinicians require clinical risk stratification tools that include accurate imaging techniques for analysing the degree of cardiac and valvular dysfunction, possible related complications and the optimal time for intervention in these patients.
  Cardiac Magnetic Resonance (CMR) is a non-invasive imaging modality that allows detailed visualization of cardiac anatomy and functional assessment, including wall motion analysis, quantification of chambers size and volume, systolic and diastolic function, and myocardial tissue characterization, without exposure to ionizing radiation. This makes CMR a valuable tool for this cohort, especially in patients with non-conclusive echocardiography, and in need to follow up imaging.
  Despite all these advantages, being a relatively new technique, CMR doesn’t have a well-defined role in the guidelines for diagnosis and management of structural heart disease. With this study, we want to determine what is the role of Cardiac MRI in these patients, and analyse which parameters assessed mainly with MRI can have a significant influence in management, and in patient’s outcome and prognosis

• REC name

  HSC REC A

• REC reference

  17/NI/0147

• Date of REC Opinion

  1 Aug 2017

• REC opinion

  Favourable Opinion